AI
NVRO

Atom Investors’s NEVRO CORP. NVRO Stock Holding History

Atom Investors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,434
Closed -$155K – 638
2024
Q2 		$155K Sell
18,434
-1,724
-9% -$18.4K 0.02% 436
2024
Q1 		$291K Buy
+20,158
New +$333K 0.04% 415
2020
Q4 		– Sell
-2,095
Closed -$292K – 603
2020
Q3 		$292K Buy
+2,095
New +$280K 0.03% 300

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Atom Investors's NVRO Position: Q3 2024 in Review

Atom Investors sold out of NEVRO CORP. (NVRO) in Q3 2024, closing a stake of 18,434 shares — an estimated $155K sold.

Atom Investors first reported a position in NVRO in Q3 2020 and held it in 3 quarters. The position peaked at $292K in Q3 2020. 131 funds tracked by Wall St. Rank hold NVRO as of Q3 2024.

  • Atom Investors reported no remaining NEVRO CORP. position as of Q3 2024 after selling out during the quarter.
  • Atom Investors sold 18,434 NEVRO CORP. shares in Q3 2024, an estimated $155K.
  • Atom Investors first reported a position in NEVRO CORP. in Q3 2020 and held it in 3 quarters.
  • Atom Investors's NEVRO CORP. position peaked at $292K in Q3 2020.
  • 131 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2024.

Based on Atom Investors's 13F filing for Q3 2024, filed 14 Nov 2024.